showed a trendP < 0.15
At baseline, diacerein-treated participants showed a trend (P < 0.15) toward lower systolic and diastolic blood pressures compared to placebo participants, which is consistent with more frequent use of ACE inhibitors.
At baseline, diacerein-treated participants showed a trend (P < 0.15) toward lower systolic and diastolic blood pressures compared to placebo participants, which is consistent with more frequent use of ACE inhibitors.
Regression analysis showed a trend to decreased sample sizes from 1990 to 2020 (β = –3.8 [95% CI, 1.4 to –9.0]; P = .15).
On the other hand, the IRP rate of all the population including all histology showed a trend, without reaching statistical significance, to higher risk in males than females (25 out 194 males, 12.9%; and 4 out 62 females, 6.5%; P = 0.15).
Plasma TMA levels of the Con + IMC group showed a trend of a decrease compared to the Con group (0.08 μM vs. 0.15 μM, p = 0.15, Supplemental Fig.
study demonstrated that the HPV-positive LSCC showed a trend towards a better 5-year survival (100% & 85%; p = 0.15) and a significant improvement in the local/regional control rate (100% & 75%; p = 0.05), comparing to HPV-negative.
However, in our multivariate analysis, even though comorbidity was not an independent predictive factor for AEs, cardiovascular disease showed a trend toward risk complications ( P = 0.15).
At the time of ROSC, the ECMO showed a trend towards better hemodynamics with higher MAP 131 vs. 89 mmHg ( p = 0.15).
The expression of CD146 showed a trend toward higher in ECs than in LCs ( p = 0.15).
In the meantime, hemiparkinsonian rats treated with intranasal SP-GNP (p = 0.001) and intravenous SP-GNP (p = 0.02) showed a significant decrease on apomorphine-induced rotation than hemiparkinsonian rats with intranasal PBS solution treatment, while those with intranasal SP solution and blank GNP treatment showed a trend of improvement without statistical significance (p = 0.15 and p = 0.35 respectively).
On univariate analysis, HLA-A alleles were significantly associated as prognostic biomarkers with early BCR ( p = 0.028; HR = 1.822), OS ( p = 0.013; HR = 1.547) and showed a trend for CR ( p = 0.150; HR = 1.239).
Although mitotic activity and vascular invasion showed a trend toward higher levels in the high SETD5 expression group, these differences did not reach statistical significance ( p = 0.15 and p = 0.12, respectively). 3.4.
However, the TWEAK administered mice showed a trend towards decreased forelimb grip strength (p = 0.15) and treadmill run fitness (p = 0.11) at 2 weeks ( Fig 3A and 3B ).
Outcome according to MDS type and karyotype Patients with a BM blast percentage of >20% at any time prior to HSCT showed a trend toward inferior DFS (0.49 [0.21–0.77]) compared to patients with 5–19% BM blasts (0.73 [0.54–0.92]) or with <5% blasts (0.81 [0.66–0.96]) ( p = 0.15; Fig. 3A ).
In addition, the subset analyses of LMCA patients in the ADAPT-DES study also showed a trend toward a reduction in MACE (HR 0.54; 95% CI 0.23–1.26; P = 0.15) [ 30 ].
This was not the case for ANGPTL4 and ApoC3, although in the case of ApoC3 the multivariable analysis showed a trend to be significant (beta coef. 0.7 [95%CI -0.3-0.17] mg/dl, p=0.15) ( Table 5 ).
Moreover, older patients showed a trend of less, yet insignificant, AKI events among new users of empagliflozin compared with that of linagliptin (aHR, 0.70, p = 0.15).
However, ide‐cel patients with high baseline sVCAM‐1 or sIL‐2R showed a trend towards worse PFS (P = 0.15; P = 0.17) (Figure S7G,J ).
Even though there was no significant difference between baseline and values at the end of the study, 8-iso-PGF 2α concentrations showed a trend to lower values in ranolazine-patients (difference −144 pmol/mg creatinine, 95% CI −355 to 66, P = 0.15, Fig. 1E ), whereas such a trend was missing in the control group.
Patients with carbapenem-resistant VARI had significantly greater ICU costs than patients with carbapenem-susceptible isolates (6053 USD (IQR 3806–7824) vs 3131 USD (IQR 2108–7551), p = 0.04) and after correction for adequacy of initial antibiotics and APACHE II score, showed a trend towards increased risk of in-hospital death (HR 2.82, 95% CI 0.75–6.75, p = 0.15).
Only the variables that appeared significant, or that showed a trend for significance (RR<0.7 or RR>1.3 and p<0.15) were considered in a multivariate model.
Moreover, the TGF-β1-TG mice showed a trend toward higher fibronectin (FBN) mRNA expression in the ventricular tissue compared to the WT animals ( p = 0.15) ( Figure 2 D).
At a low concentration of 0.2 μM, CP96,345 showed a trend of inhibition (0.05 < P < 0.15) but at higher concentrations (5 μM), it completely abolished SP-induced up-regulation of PPTA/NK1R mRNA expression ( Fig. 2A and B).
Some variables showed a trend toward association without reaching statistical significance, such as previous AHF episodes (OR 1.58; 95% CI 0.85–2.95; p = 0.15), respiratory rate >30 bpm (OR 2.08; 95% CI 0.65–6.61; p = 0.22), or hospital admission (OR 2.10; 95% CI 0.93–4.78; p = 0.08).
The left-ventricular anterior wall thickness (LVAWs; 0.39 ± 0.02 mm compared with 0.48 ± 0.02 mm, p = 0.02) was lower ( Fig 2D ), while internal diameter (LVIDs; 1.37 ± 0.04 mm compared with 1.04 ± 0.12 mm, p = 0.0220) at systole, was significantly higher, as was the left-ventricular internal diameter at diastole (LVIDd), which showed a trend towards being increased (1.76 ± 0.03 mm compared with 1.61 ± 0.10 mm, p = 0.15) ( Fig 2E and 2F ).
Conjectural Implications of White Matter Development on Communication Efficacy Network and Integration Capacity Communication hubs in the neonatal brain (12 nodes, selected as described above) showed a trend-level increase in betweenness centrality—indicating the level of central placement of hubs in the overall network—over time ( r = 0.28, P = 0.15 ns, Fig. 5 c ), suggestive of a possible, but modest increase in the level of centrality of these nodes in the overall network during development.